InsideArbitrage February 2025 Mid-Month Update – Portfolio Updates
Instead of discussing a new idea for our February mid-month update, I figured I would briefly touch on five different situations, four of which are in the model portfolio and one is an interesting merger arbitrage situation with a hostile bid.
1. Avadel Pharmaceuticals (AVDL): $8.61
Market Cap: $866.29M
Enterprise Value: $838.74M
We discussed Avadel Pharmac…
Keep reading with a 7-day free trial
Subscribe to The Special Situation Report to keep reading this post and get 7 days of free access to the full post archives.